Frank Rimerman Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
4,402
-1,752
-28% -$141K 0.02% 466
2026
Q1
$435K Sell
6,154
-2,201
-26% -$165K 0.03% 409
2025
Q4
$660K Buy
8,355
+2,263
+37% +$179K 0.04% 315
2025
Q3
$502K Sell
6,092
-3,642
-37% -$287K 0.03% 372
2025
Q2
$783K Buy
9,734
+839
+9% +$64.7K 0.05% 251
2025
Q1
$714K Sell
8,895
-220
-2% -$18.3K 0.06% 248
2024
Q4
$746K Buy
9,115
+1,163
+15% +$96.8K 0.05% 235
2024
Q3
$656K Buy
7,952
+3,434
+76% +$257K 0.05% 283
2024
Q2
$317K Buy
4,518
+4,424
+4,706% +$316K 0.02% 435
2024
Q1
$6.97K Hold
94
﹤0.01% 193
2023
Q4
$6.22K Buy
+94
New +$5.88K ﹤0.01% 190

Other funds holding MET

Frank Rimerman Advisors's MET Position: Q2 2026 in Review

Frank Rimerman Advisors reduced its MetLife (MET) stake by 28% in Q2 2026, selling an estimated $141K and leaving 4,402 shares worth $372K. The position accounts for 0.02% of the portfolio, ranked #466.

Frank Rimerman Advisors first reported a position in MET in Q4 2023 and has held it in 11 quarters since. The position peaked at $783K in Q2 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Frank Rimerman Advisors held 4,402 shares of MetLife worth $372K as of Q2 2026.
  • Frank Rimerman Advisors sold 1,752 MetLife shares in Q2 2026, an estimated $141K.
  • MetLife made up 0.02% of Frank Rimerman Advisors's portfolio in Q2 2026, its #466 holding.
  • Frank Rimerman Advisors first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • Frank Rimerman Advisors's MetLife position peaked at $783K in Q2 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.